Hints and tips:
Related Special Reports
...company’s biggest-selling drugs....
...Shares in Eli Lilly, which last year became the biggest pharmaceutical group by market value, were up 7.5 per cent in pre-market trading....
...above $700bn, making it the world’s biggest pharmaceutical group by market value....
...AstraZeneca beat analysts’ estimates with 19 per cent growth in revenue in the first quarter of 2024, driven by stronger sales of its cancer drugs....
...The US biotech company reported first-quarter earnings of $3.67 a share, beating analysts’ consensus estimates of $3.44. That pushed Biogen’s shares up 4.3 per cent in early trading on Wednesday....
...Companies linked to the drug lost a combined $40bn in value in days. Pharma groups contest the lab’s results and practices....
...The companies have dual-listed in Canada — where marijuana has been legal since 2018 — and their shares also soared on Toronto’s main stock index....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...The company has genetically validated two other drug targets....
...Patients with terminal breast cancer in England will be denied access to a new treatment that has already been approved in Scotland, after a public health body said the drug did not provide value for money...
...It is also working with another pharmaceuticals company to lower the price of insulin through the scheme, and officials said they were looking for ways to lower the price of other drugs in the state....
...A top EU court has ruled that the name of the dead Colombian drug kingpin Pablo Escobar cannot be registered as a trademark in the EU....
...Patients with terminal breast cancer in England will miss out on a new drug already approved in Scotland, after spending watchdog NICE said Enhertu, developed by Japanese pharma company Daiichi Sankyo and...
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...It is now raising $600mn to launch its pioneering drug Rezdiffra in the US. Madrigal’s market value is about $5.1bn....
...Joe Biden’s administration is planning to reclassify cannabis as a less harmful drug with a smaller legal penalty, in a historic shift for US drug policy, said people familiar with the matter....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...Hong Kong-based activist fund Oasis Management has bought a 9.6 per cent stake in the company, which has a market value of $1.2bn....
...The company’s immunotherapy drug Imfinzi helped patients with so-called limited stage small cell lung cancer survive for longer....
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...The company plans to “move forward as quickly as possible” with further trials in MASH for the drug....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...In its 2023 financial report, the company said the value of its primate assets had fallen by about $40mn....
International Edition